Clinical studies recruiting near Ningbo

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Ningbo First Hospital · Eli Lilly and Company · NCT07218380 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · The first affiliated hospital of Ningbo university · Pfizer · NCT07028853 Intraventricular Administration of Intracranial Infections Caused by （Carbapenem-resistant Gram-negative Bacilli）CRGNB
Phase N/A · Ningbo Medical Center Lihuili Hospital · Second Affiliated Hospital, Zhejiang University, School of M · NCT06595979 A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · Ningbo Second Hospital · Huabo Biopharm Co., Ltd. · NCT06592274 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Local Institution - 0182 · Bristol-Myers Squibb · NCT06929273 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The Affiliated People's Hospital of Ningbo University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · The Affiliated People's Hospital of Ningbo University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320 Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Phase 3 · Ningbo Medical Center Lihuili Hospital · The Affiliated People's Hospital of Ningbo University · NCT06520176 The Chinese Familial Alzheimer's Network
Phase N/A · Ningbo City Medical Treatment Center Lihuili Hospital · Capital Medical University · NCT03657732 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · The First Affiliated Hospital of Ningbo University · Amgen · NCT07037433 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · The first affiliated hospital of Ningbo university · Pfizer · NCT07421700 Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Phase 3 · Ningbo Medical Center Lihuili Hospital · The Affiliated People's Hospital of Ningbo University · NCT06520163 Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (
Phase 3 · Ningbo Medical Center Lihuili Hospital · Fudan University · NCT05909332 Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · Ningbo Medical Center Lihuili Hospital · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525 Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
Phase 2 · Ningbo Medical Center Lihuili Hospital · Zhejiang Provincial People's Hospital · NCT05446467 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Ningbo First Hospital · Eli Lilly and Company · NCT07369011 Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
Phase 2 · the Affiliated Peopele'S Hospital of Ningbo University · Second Affiliated Hospital, Zhejiang University, School of M · NCT07022223 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0112 · Celgene · NCT05519085 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · The First Affiliated Hospital Of Ningbo University · Amgen · NCT07005128 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · The First Affiliated Hospital of Ningbo University · Boehringer Ingelheim · NCT07220083 Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicent
Phase N/A · Ningbo No.2 Hospital · Shanghai Pulmonary Hospital, Shanghai, China · NCT07243873 Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NA · Ningbo NO.2 Hospital · Peking Union Medical College Hospital · NCT05866029 CHiR Therapy for Elderly DLBCL Intolerant to Chemo
Phase 2 · The First Affiliated Hospital of Ningbo University · First Affiliated Hospital of Ningbo University · NCT06764017 The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib
NA · Kaitai Liu · Ningbo Medical Center Lihuili Hospital · NCT06188650 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · The first affiliated hospital of Ningbo university · Eli Lilly and Company · NCT07353931 Combined Screening for Gastrointestinal Tumors
Phase N/A · Fenghua District · Zhejiang Cancer Hospital · NCT06478030 The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management
NA · Research Site · AstraZeneca · NCT06909773 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Ningbo Medical Center Lihuili Hospital · Eli Lilly and Company · NCT06338995 REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry
Phase 4 · The First Affiliated Hospital of Ningbo University · Nanfang Hospital, Southern Medical University · NCT05728775

Look up another city

Look up another condition